Cargando…

PARP-1 Modulation of mTOR Signaling in Response to a DNA Alkylating Agent

Poly(ADP-ribose) polymerase-1 (PARP-1) is widely involved in cell death responses. Depending on the degree of injury and on cell type, PARP activation may lead to autophagy, apoptosis or necrosis. In HEK293 cells exposed to the alkylating agent N-methyl-N’-nitro-N’-nitrosoguanine (MNNG), we show tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Éthier, Chantal, Tardif, Maxime, Arul, Laura, Poirier, Guy G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480502/
https://www.ncbi.nlm.nih.gov/pubmed/23110147
http://dx.doi.org/10.1371/journal.pone.0047978
_version_ 1782247578184712192
author Éthier, Chantal
Tardif, Maxime
Arul, Laura
Poirier, Guy G.
author_facet Éthier, Chantal
Tardif, Maxime
Arul, Laura
Poirier, Guy G.
author_sort Éthier, Chantal
collection PubMed
description Poly(ADP-ribose) polymerase-1 (PARP-1) is widely involved in cell death responses. Depending on the degree of injury and on cell type, PARP activation may lead to autophagy, apoptosis or necrosis. In HEK293 cells exposed to the alkylating agent N-methyl-N’-nitro-N’-nitrosoguanine (MNNG), we show that PARP-1 activation triggers a necrotic cell death response. The massive poly(ADP-ribose) (PAR) synthesis following PARP-1 activation leads to the modulation of mTORC1 pathway. Shortly after MNNG exposure, NAD(+) and ATP levels decrease, while AMP levels drastically increase. We characterized at the molecular level the consequences of these altered nucleotide levels. First, AMP-activated protein kinase (AMPK) is activated and the mTORC1 pathway is inhibited by the phosphorylation of Raptor, in an attempt to preserve cellular energy. Phosphorylation of the mTORC1 target S6 is decreased as well as the phosphorylation of the mTORC2 component Rictor on Thr1135. Finally, Akt phosphorylation on Ser473 is lost and then, cell death by necrosis occurs. Inhibition of PARP-1 with the potent PARP inhibitor AG14361 prevents all of these events. Moreover, the antioxidant N-acetyl-L-cysteine (NAC) can also abrogate all the signaling events caused by MNNG exposure suggesting that reactive oxygen species (ROS) production is involved in PARP-1 activation and modulation of mTOR signaling. In this study, we show that PARP-1 activation and PAR synthesis affect the energetic status of cells, inhibit the mTORC1 signaling pathway and possibly modulate the mTORC2 complex affecting cell fate. These results provide new evidence that cell death by necrosis is orchestrated by the balance between several signaling pathways, and that PARP-1 and PAR take part in these events.
format Online
Article
Text
id pubmed-3480502
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-34805022012-10-29 PARP-1 Modulation of mTOR Signaling in Response to a DNA Alkylating Agent Éthier, Chantal Tardif, Maxime Arul, Laura Poirier, Guy G. PLoS One Research Article Poly(ADP-ribose) polymerase-1 (PARP-1) is widely involved in cell death responses. Depending on the degree of injury and on cell type, PARP activation may lead to autophagy, apoptosis or necrosis. In HEK293 cells exposed to the alkylating agent N-methyl-N’-nitro-N’-nitrosoguanine (MNNG), we show that PARP-1 activation triggers a necrotic cell death response. The massive poly(ADP-ribose) (PAR) synthesis following PARP-1 activation leads to the modulation of mTORC1 pathway. Shortly after MNNG exposure, NAD(+) and ATP levels decrease, while AMP levels drastically increase. We characterized at the molecular level the consequences of these altered nucleotide levels. First, AMP-activated protein kinase (AMPK) is activated and the mTORC1 pathway is inhibited by the phosphorylation of Raptor, in an attempt to preserve cellular energy. Phosphorylation of the mTORC1 target S6 is decreased as well as the phosphorylation of the mTORC2 component Rictor on Thr1135. Finally, Akt phosphorylation on Ser473 is lost and then, cell death by necrosis occurs. Inhibition of PARP-1 with the potent PARP inhibitor AG14361 prevents all of these events. Moreover, the antioxidant N-acetyl-L-cysteine (NAC) can also abrogate all the signaling events caused by MNNG exposure suggesting that reactive oxygen species (ROS) production is involved in PARP-1 activation and modulation of mTOR signaling. In this study, we show that PARP-1 activation and PAR synthesis affect the energetic status of cells, inhibit the mTORC1 signaling pathway and possibly modulate the mTORC2 complex affecting cell fate. These results provide new evidence that cell death by necrosis is orchestrated by the balance between several signaling pathways, and that PARP-1 and PAR take part in these events. Public Library of Science 2012-10-24 /pmc/articles/PMC3480502/ /pubmed/23110147 http://dx.doi.org/10.1371/journal.pone.0047978 Text en © 2012 Éthier et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Éthier, Chantal
Tardif, Maxime
Arul, Laura
Poirier, Guy G.
PARP-1 Modulation of mTOR Signaling in Response to a DNA Alkylating Agent
title PARP-1 Modulation of mTOR Signaling in Response to a DNA Alkylating Agent
title_full PARP-1 Modulation of mTOR Signaling in Response to a DNA Alkylating Agent
title_fullStr PARP-1 Modulation of mTOR Signaling in Response to a DNA Alkylating Agent
title_full_unstemmed PARP-1 Modulation of mTOR Signaling in Response to a DNA Alkylating Agent
title_short PARP-1 Modulation of mTOR Signaling in Response to a DNA Alkylating Agent
title_sort parp-1 modulation of mtor signaling in response to a dna alkylating agent
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480502/
https://www.ncbi.nlm.nih.gov/pubmed/23110147
http://dx.doi.org/10.1371/journal.pone.0047978
work_keys_str_mv AT ethierchantal parp1modulationofmtorsignalinginresponsetoadnaalkylatingagent
AT tardifmaxime parp1modulationofmtorsignalinginresponsetoadnaalkylatingagent
AT arullaura parp1modulationofmtorsignalinginresponsetoadnaalkylatingagent
AT poirierguyg parp1modulationofmtorsignalinginresponsetoadnaalkylatingagent